Therapeutic Asset Ratings
120 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ALECTINIB
Metastatic Colorectal Cancer
Oslo University Hospital
P2
CCC
(48)
Crisaborole
Metastatic Colorectal Cancer
Sun Yat-sen University
P2
CCC
(48)
Crizotinib
Metastatic Colorectal Cancer
Oslo University Hospital
P2
CCC
(48)
ENFORTUMAB VEDOTIN (fully human monoclonal antibody conjugated to a cytotoxic agent monomethyl auristatin E (MMAE) targeting nectin-4)
Metastatic Colorectal Cancer
H. Lee Moffitt Cancer Center and Research Institute
P2
CCC
(48)
hlx208
Metastatic Colorectal Cancer
Shanghai Henlius Biotech
P2
CCC
(48)
Hydroxychloroquine
Metastatic Colorectal Cancer
University Health Network, Toronto
P2
CCC
(48)
js207
Metastatic Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd.
P2
CCC
(48)
js212
Metastatic Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd.
P2
CCC
(48)
Larotrectinib
Metastatic Colorectal Cancer
Oslo University Hospital
P2
CCC
(48)
Ligufalimab
Metastatic Colorectal Cancer
Akeso
P2
CCC
(48)
Max-40279-01
Metastatic Colorectal Cancer
Maxinovel Pty., Ltd.
P2
CCC
(48)
Niraparib
Metastatic Colorectal Cancer
Ospedale Policlinico San Martino
P2
CCC
(48)
Penpulimab
Metastatic Colorectal Cancer
Fudan University
P2
CCC
(48)
Petrozumab
Metastatic Colorectal Cancer
Oslo University Hospital
P2
CCC
(48)
rbs2418
Metastatic Colorectal Cancer
Riboscience, LLC.
P2
CCC
(48)
sc0191
Metastatic Colorectal Cancer
Tianshu Liu
P2
CCC
(48)
Sotevtamab
Metastatic Colorectal Cancer
Alethia Biotherapeutics
P2
CCC
(48)
Ssgj-707
Metastatic Colorectal Cancer
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
P2
CCC
(48)
Talzenna
Metastatic Colorectal Cancer
Oslo University Hospital
P2
CCC
(48)
Thalidomide
Metastatic Colorectal Cancer
Fujian Cancer Hospital
P2
CCC
(48)
Tinodasertib
Metastatic Colorectal Cancer
AUM Biosciences Pte Ltd
P2
CCC
(48)
Tovecimig
Metastatic Colorectal Cancer
Washington University School of Medicine
P2
CCC
(48)
Valproic Acid
Metastatic Colorectal Cancer
Australasian Gastro-Intestinal Trials Group
P2
CCC
(48)
Vancomycin
Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
P2
CCC
(48)
Venetoclax
Metastatic Colorectal Cancer
Oslo University Hospital
P2
CCC
(48)
Showing 51 to 75 of 120 assets
Previous
Page 3 of 5
Next
